Modulation of oral bioavailability of anticancer drugs: from mouse to man

By Schellens J.H.M.   Malingre M.M.   Kruijtzer C.M.F.   Bardelmeijer H.A.   van Tellingen O.   Schinkel A.H.   Beijnen J.H.  

European Journal of Pharmaceutical Sciences, Vol. 12, Iss. 2, 2000-12 ,pp. : 103-110

Elsevier

Access to resources Recommend Favorite

The US FDA is seeking paediatric formulations of oral anticancer drugs

By  

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Estimating kidney function and use of oral antidiabetic drugs in elderly

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 3, 2015-06 ,pp. : 321-328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates

By  

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-12 ,pp. : 4374-4404

Bentham Science Publishers

Access to resources Recommend Favorite

A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 14, 2007-07 ,pp. : 1408-1422

Bentham Science Publishers

Access to resources Recommend Favorite